cytidine diphosphate choline has been researched along with simvastatin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Huang, L; Jiang, L; Miao, H | 1 |
Azadi, A; Azadi, S; Farjadian, F; Mohammadi Samani, S; Mozafari, N | 1 |
3 other study(ies) available for cytidine diphosphate choline and simvastatin
Article | Year |
---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Effects of simvastatin on the expression of intercellular adhesion molecule-1 mRNA in neonatal brain with hypoxic-ischemic damage.
Topics: Animals; Animals, Newborn; Base Sequence; Brain; Cerebral Cortex; Cytidine Diphosphate Choline; DNA, Complementary; Female; Gene Expression; Hippocampus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoxia-Ischemia, Brain; Intercellular Adhesion Molecule-1; Male; Nanotechnology; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Simvastatin | 2005 |
Simvastatin-chitosan-citicoline conjugates nanoparticles as the co-delivery system in Alzheimer susceptible patients.
Topics: Alzheimer Disease; Chitosan; Cytidine Diphosphate Choline; Disease Susceptibility; Drug Carriers; Humans; Nanoparticles; Simvastatin | 2020 |